Chronopharmacology of anti-convulsive therapy

Current Neurology and Neuroscience Reports

Volumn 13, Issue 4, 2013, Pages

  Ramgopal, Sriram ^a,b   Thome Souza, Sigride ^a,b   Loddenkemper, Tobias ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronopharmacodynamics; Chronopharmacokinetics; Chronopharmacology; Chronotherapy; Circadian pattern; Circadian rhythms; Closedloops; Differential dosing; Dimlight melatonin onset; Diurnal patterns; DLMO; Epilepsy; Lighttherapy; Melatonin; Pharmacodynamics; Pharmacokinetics; Seizure diary; Seizure patterns; Seizures; Seizuretracking; Suprachiasmatic nucleus

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; DIAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; MELATONIN; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ANTICONVULSANT THERAPY; AREA UNDER THE CURVE; ARTICLE; CEREBROSPINAL FLUID; CHRONOPHARMACOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); DIGESTION; DISEASE CONTROL; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; ELECTROENCEPHALOGRAM; EMBRYOTOXICITY; EPILEPSY; EVENING DOSAGE; FATIGUE; FOLLOW UP; GENETIC TRANSCRIPTION; HUMAN; MAXIMUM PLASMA CONCENTRATION; MORNING DOSAGE; NONHUMAN; PHARMACODYNAMICS; PHOTOTHERAPY; SEIZURE SUSCEPTIBILITY; SLEEP DEPRIVATION; SLEEP WAKING CYCLE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84874385466     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-013-0339-2     Document Type: Article

References (112)

1. MacDonald BK, Johnson AL, Goodridge D.M., Cockerell OC, Sander JW, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol. 2000; 48: 833-41.
2. Kahane P. Epilepsy surgery in adult pat (Pubitemid 39220907)
3. Liu L, Henry JC. New-onset partial epilepsy in adults. Curr Treat Options Neurol. 2009; 11: 242-52.
4. Uthman BM. Vagus nerve stimulation for seizures. Arch Med Res. 2000; 31: 300-3.
5. Durazzo TS, Spencer SS, Duckrow R.B., Novotny EJ, Spencer DD, Zaveri HP. Temporal distributions of seizure occurrence from various epileptogenic regions. Neurology. 2008; 70: 1265-71. This study evaluates the diurnal occurrence of seizures in an adult series in which epilepsy was sufficiently localized for surgical resection. (Pubitemid 351520950)
6. Loddenkemper T, Vendrame M, Zarowski M., Gregas M, Alexopoulos AV, Wyllie E, et al. Circadian patterns of pediatric seizures. Neurology. 2011; 76: 145-53.
7. Pavlova MK, Woo Lee J, Yilmaz F, Dworetzky BA. Diurnal pattern of seizures outside the hospital: is there a time of circadian vulnerability? Neurology. 2012; 78: 1488-92. This study evaluates diurnal seizure patterns in patients undergoing ambulatory EEG.
8. Guilhoto LM, Loddenkemper T, Vendrame M., Bergin A, Bourgeois BF, Kothare SV Higher evening antiepileptic drug dose for nocturnal and early-morning seizures. Epilepsy Behav. 2011; 20: 334-7. This is a differential dosing strategy in epilepsy reported to date. Uses patients with refractory epilepsy with nocturnal or early morning seizure clusters.
9. Yegnanarayan R, Mahesh SD, Sangle S. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. Chronobiol Int. 2006; 23: 1035-46. This is one of the earliest trials of differential dosing strategy in epilepsy and is the largest published cohort to date. Used patients with subtherapeutic drug troughs. (Pubitemid 44595011)
10. Hofstra WA, de Weerd AW. How to assess circadian rhythm in humans: A review of literature. Epilepsy Behav. 2008; 13: 438-44.
11. Molina TA, Burgess HJ. Calculating the dim light melatonin onset: the impact of threshold and sampling rate. Chronobiol Int. 2011; 28: 714-8.
12. Sharkey KM, Carskadon MA, Figueiro M.G., Zhu Y., Rea MS. Effects of an advanced sleep schedule and morning short wavelength light exposure on circadian phase in young adults with late sleep schedules. Sleep Med. 2011; 12: 685-92.
13. Shekleton JA, Parcell DL, Redman J.R., Phipps-Nelson J, Ponsford JL, Rajaratnam SM. Sleep disturbance and melatonin levels following traumatic brain injury. Neurology. 2010; 74: 1732-8.
14. Conroy DA, Hairston IS, Arnedt J.T., Hoffmann RF, Armitage R, Brower KJ. Dim light melatonin onset in alcohol-dependent men and women compared with healthy controls. Chronobiol Int. 2012; 29: 35-42.
15. Hofstra WA, Gordijn MCM, van der Palen J, van Regteren R, Grootemarsink BE, de Weerd AW. Timing of temporal and frontal seizures in relation to the circadian phase: A prospective pilot study. Epilepsy Res. 2011; 94: 158-62.
16. Waterhouse J, Weinert D, Minors D., Folkard S, Owens D, Atkinson G., et al. A comparison of some different methods for purifying core temperature data from humans. Chronobiol Int. 2000; 17: 539-66. (Pubitemid 30463740)
17. Dijk DJ, Czeisler CA. Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans. Neurosci Lett. 1994; 166: 63-8. (Pubitemid 24047900)
18. Youan BB. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J Control Release. 2004; 98: 337-53.
19. Singh R, Sharma PK, Malviya R. Circadian cycle and chrono-therapeutics: recent trend for the treatment of various biological disorders. Recent Pat Drug Deliv Formul. 2012; 6: 80-91. This review discusses the potential uses, and various dosing preparations for chronopharmacology.
20. Acelajado MC, Pisoni R, Dudenbostel T., Oparil S, Calhoun DA, Glasser SP Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients. J Am Soc Hypertens. 2012; 6: 66-72.
21. Kenny AM, Schneider MB, Baden D.R., Pfeiffer RF, Murrin LC. Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats. Neurology. 1986; 36: 400-4. (Pubitemid 16125164)
22. Sato Y, Kobayashi E, Hakamata Y., Kobahashi M, Wainai T, Murayama T., et al. Chronopharmacological studies of ketamine in normal and NMDA epsilon1 receptor knockout mice. Br J Anaesth. 2004; 92: 859-64. (Pubitemid 38771689)
23. Tekade AR, Gattani SG Dual cross-linked pulsatile beads for chronotherapy of asthma: development and evaluation. Drug Deliv. 2010; 17: 581-6.
24. Tsioufis C, Kasiakogias A, Thomopoulos C., Stefanadis C. Nighttime blood pressure in diabetes: better treat it than leave it. Am J Hyper-tens. 2012; 25: 279.
25. Shea SA. Obesity and pharmacologic control of the body clock. N Engl J Med. 2012; 367: 175-8.
26. Etienne-Grimaldi M.C., Cardot JM, Francois E, Renee N., Douillard JY, Gamelin E, et al. Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients. Clin Pharmacol Ther. 2008; 83: 413-5. (Pubitemid 351272628)
27. Portaluppi F, Hermida RC Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv Drug Deliv Rev. 2007; 59: 940-51. (Pubitemid 47534217)
28. Ezeugo U, Glasser SP. Clinical benefits vs shortcomings of diltia-zem once-daily in the chronotherapy of cardiovascular diseases. Expert Opin Pharmacother. 2009; 10: 485-91.
29. Lieverse R, der Lek RF R-v, Voermans JM, Hoogendijk WJ. Chronotherapy for affective disorders. Tijdschr Psychiatr. 2012; 54: 527-37.
30. Karwa R, Shashank A, Rambhau D., Gopinath D, Ravi D. Time-dependent pharmacokinetic interaction between zidovudine and rifampicin following oral administration at 10.00 and 22.00 hours. Drug Metabol Drug Interact. 2001; 18: 123-34. (Pubitemid 34855414)
31. King AB, Clark D, Wolfe GS. How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus. Endocr Pract. 2012; 18: 382-6.
32. Gowers, W. Epilepsy and other chronic convulsive diseases: their causes, symptoms and treatment. New York: William Wood; 1885.
33. Manfredini R, Vergine G, Boari B., Faggioli R, Borgna-Pignatti C. Circadian and seasonal variation of first febrile seizures. J Pediatr. 2004; 145: 838-9. (Pubitemid 39586626)
34. Cortez MA, Burnham WM, Hwang PA. Infantile spasms: seasonal onset differences and zeitgebers. Pediatr Neurol. 1997; 16: 220-4. (Pubitemid 27214891)
35. Misra UK, Kalita J. Overview: Japanese encephalitis. Prog Neuro-biol. 2010; 91: 108-20.
36. Hofstra WA, Grootemarsink BE, Dieker R, van der Palen J, de Weerd AW. Temporal distribution of clinical seizures over the 24 hday: A retrospective observational study in a tertiary epilepsy clinic. Epilepsia. 2009; 50: 2019-26. This pilot study is the first to associate seizures to a circadian biomarker, namely dim-light melatonin onset.
37. Pavlova MK, Shea SA, Bromfield EB. Day/night patterns of focal seizures. Epilepsy Behav. 2004; 5(1): 44-9. (Pubitemid 38937063)
38. Karafin M, St Louis EK, Zimmerman MB, Sparks JD, Granner MA. Bimodal ultradian seizure periodicity in human mesial temporal lobe epilepsy. Seizure. 2010; 19: 347-51.
39. Zarowski M, Loddenkemper T, Vendrame M., Alexopoulos AV, Wyllie E, Kothare SV. Circadian distribution and sleep/wake patterns of generalized seizures in children. Epilepsia. 2011; 52: 1076-83. This article discusses the importance of age considerations in seizure timing and is the first to consider how these factors may change with time.
40. Ramgopal S, Shah A, Zarowski M., Vendrame M, Gregas M, Alexopoulos A.V., et al. Diurnal and sleep/wake patterns of epileptic spasms in different age groups. Epilepsia. 2012; 53: 1170-7.
41. Ramgopal S, Vendrame M, Shah A., Gregas M, Zarowski M, Rotenberg A., et al. Circadian patterns of generalized tonic-clonic evolutions in pediatric epilepsy patients. Seizure. 2012; 21: 535-9.
42. Sánchez Fernández I, Ramgopal S, Powell C, Gregas M, Zarowski M, Shah A, et al. Clinical evolution of seizures: distribution across time of day and sleep/wakefulness cycle. J Neurol. 2012; 26: 549-57.
43. Nobili L, Cardinale F, Magliola U., Cicolin A, Didato G, Bramerio M., et al. Taylor's focal cortical dysplasia increases the risk of sleep-related epilepsy. Epilepsia. 2009; 50: 2599-604.
44. Crespel A, Baldy-Moulinier M, Coubes P. The relationship between sleep and epilepsy in frontal and temporal lobe epilepsies: practical and physiopathologic considerations. Epilepsia. 1998; 39: 150-7. (Pubitemid 28074350)
45. Herman ST, Walczak TS, Bazil CW. Distribution of partial seizures during the sleep - wake cycle: differences by seizure onset site. Neurology. 2001; 56: 1453-9. (Pubitemid 32532256)
46. Sinha S, Brady M, Scott C.A., Walker MC. Do seizures in patients with refractory epilepsy vary between wakefulness and sleep? J Neurol Neurosurg Psychiatry. 2006; 77: 1076-8. (Pubitemid 44338535)
47. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia. 1997; 38: 1082-8. (Pubitemid 27424151)
48. Foldvary-Schaefer N., Harden C, Herzog A., Falcone T. Hormones and seizures. Cleve Clin J Med. 2004; 71 Suppl 2: S11-8.
49. Baxendale S, Fisher J. Moonstruck? The effect of the lunar cycle on seizures. Epilepsy Behav. 2008; 13: 549-50.
50. Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: A 5-year prospective study. Epilepsia. 1994; 35: 285-96. (Pubitemid 24138810)
51. Ruiz-Miyares F., Siegmund R, Wermke K., Dorado-Gallego J, Escobedo-Beceiro DI. West syndrome: A chronobiological approach. Rev Neurol. 2000; 30: 925-8. (Pubitemid 30436268)
52. Engel Jr J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001; 42: 796-803. (Pubitemid 32605946)
53. Yalyn O, Arman F, Erdogan F., Kula M. A comparison of the circadian rhythms and the levels of melatonin in patients with diurnal and nocturnal complex partial seizures. Epilepsy Behav. 2006; 8: 542-6.
54. Molina-Carballo A., Munoz-Hoyos A, Rodriguez-Cabezas T, Acuna-Castroviejo D. Day-night variations in melatonin secretion by the pineal gland during febrile and epileptic convulsions in children. Psychiatry Res. 1994; 52: 273-83. (Pubitemid 24225425)
55. Larson AM, Ryther RC, Jennesson M, Geffrey A.L., Bruno PL, Anagnos CJ, et al. Impact of pediatric epilepsy on sleep patterns and behaviors in children and parents. Epilepsia. 2012; 53: 1162-9. Excellent review documenting the effects of epilepsy on sleep patterns.
56. Kothare SV, Zarowski M. Sleep and epilepsy: common bedfellows. J Clin Neurophysiol. 2011; 28: 101-2.
57. Fountain NB, Kim JS, Lee SI. Sleep deprivation activates epileptiform discharges independent of the activating effects of sleep. J Clin Neurophysiol. 1998; 15: 69-75. (Pubitemid 29090725)
58. Bruguerolle B. Chronopharmacokinetics. Current status. Clin Pharmacokinet. 1998; 35: 83-94.
59. Baraldo M. The influence of circadian rhythms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol. 2008; 4: 175-92. (Pubitemid 351308416)
60. Ohdo S. Chronopharmacology focused on biological clock. Drug Metab Pharmacokinet. 2007; 22: 3-14.
61. Labrecque G, Belanger PM. Biological rhythms in the absorption, distribution, metabolism, and excretion of drugs. Pharmacol Ther. 1991; 52: 95-107.
62. Ohdo S, Nakano S, Ogawa N. Chronopharmacokinetics of valproic acid following constant-rate administration in mice. Chrono-biol Int. 1991; 8: 35-43.
63. Meinardi H, Van Der Kleijn E, Meijer JW, Van Rees H. Absorption and distribution of antiepileptic drugs. Epilepsia. 1975; 16: 353-65.
64. Theisohn M, Assion HJ, Werner U. Influence of breakfast and day time on the disposition of carbamazepine in healthy volunteers after intake of single dose (600 mg) of a standard or retard preparation of carbamazepine. Chronopharmacology in Therapy of the Epilepsies. New York: Raven Press; 1989. p. 31-54.
65. Ohdo S, Nakano S, Ogawa N. Circadian changes of valproate kinetics depending on meal condition in humans. J Clin Pharmacol. 1992; 32: 822-6.
66. Patel IH, Venkataramanan R, Levy R.H., Viswanathan CT, Ojemann LM. Diurnal oscillations in plasma protein binding of valproic acid. Epilepsia. 1982; 23: 283-90. (Pubitemid 12082141)
67. Shirkey RJ, Jellett LB, Kappatos D.C., Maling TJ, Macdonald A. Distribution of sodium valproate in normal whole blood and in blood from patients with renal or hepatic disease. Eur J Clin Pharmacol. 1985; 28: 447-52. (Pubitemid 15063816)
68. Oishi K, Ohkura N, Kadota K., Kasamatsu M, Shibusawa K, Matsuda J., et al. Clock mutation affects circadian regulation of circulating blood cells. J Circadian Rhythms. 2006; 4: 13.
69. Yoshiyama Y, Nakano S, Ogawa N. Chronopharmacokinetic study of valproic acid in man: comparison of oral and rectal administration. J Clin Pharmacol. 1989; 29: 1048-52. (Pubitemid 20038088)
70. Klotz U, Reimann IW. Chronopharmacokinetic study with prolonged infusion of midazolam. Clin Pharmacokinet. 1984; 9: 469-74. (Pubitemid 14021625)
71. Nakano S, Watanabe H, Nagai K., Ogawa N. Circadian stage-dependent changes in diazepam kinetics. Clin Pharmacol Ther 1984; 36: 271-7. (Pubitemid 14064861)
72. Olano I, Vázquez M, Fagiolino P. Chronopharmacocinétique de la carbamazépine et de son métabolite 10.11 époxide. Journal de Pharmacie Clinique. 1998; 17: 153-6. (Pubitemid 28496773)
73. Stokkan KA, Yamazaki S, Tei H., Sakaki Y, Menaker M. Entrainment of the circadian clock in the liver by feeding. Science. 2001; 291: 490-3. (Pubitemid 32097074)
74. Tunon MJ, Gonzalez P, Lopez P., Salido GM, Madrid JA. Circadian rhythms in glutathione and glutathione-S transferase activity of rat liver. Arch Int Physiol Biochim Biophys. 1992; 100: 83-7.
75. Jaeschke H, Wendel A. Diurnal fluctuation and pharmacological alteration of mouse organ glutathione content. Biochem Pharmacol. 1985; 34: 1029-33. (Pubitemid 15054410)
76. Takiguchi T, Tomita M, Matsunaga N., Nakagawa H, Koyanagi S, Ohdo S. Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells. Pharmacogenet Genomics. 2007; 17: 1047-56. (Pubitemid 351339489)
77. Fuse Y, Hirao A, Kuroda H., Otsuka M, Tahara Y, Shibata S. Differential roles of breakfast only (1 meal per day) and a bigger breakfast with a small dinner (2 meals per day) in mice fed a high-fat diet with regard to induced obesity and lipid metabolism. J Circadian Rhythms. 2012; 10: 4.
78. Vagnucci AH, Shapiro AP, McDonald Jr RH. Effects of upright posture on renal electrolyte cycles. J Appl Physiol. 1969; 26: 720-31.
79. Gumz ML, Cheng KY, Lynch I.J., Stow LR, Greenlee MM, Cain BD, et al. Regulation of alphaENaC expression by the circadian clock protein Period 1 in mpkCCD(c14) cells. Biochim Biophys Acta. 2010; 1799: 622-9.
80. Min HK, Jones JE, Flink EB. Circadian variations in renal excretion of magnesium, calcium, phosphorus, sodium, and potassium during frequent feeding and fasting. Fed Proc. 1966; 25: 917-21.
81. Reith DM, Andrews J, McLaughlin D. Valproic acid has temporal variability in urinary clearance of metabolites. Chronobiol Int. 2001; 18: 123-9. (Pubitemid 32193771)
82. Hofstra WA, van der Palen J, de Weerd AW. Morningness and eveningness: when do patients take their antiepileptic drugs? Epilepsy Behav 2012; 23: 320-3. Excellent study evaluating the effect of behavioral/chronotype patterns in the timing of drug administration.
83. Oggier DM, Weisbrod CJ, Stoller A.M., Zenker AK, Fent K. Effects of diazepam on gene expression and link to physiological effects in different life stages in zebrafish Danio rerio. Environ Sci Technol. 2010; 44: 7685-91.
84. Ohdo S, Nakano S, Ogawa N. Chronotoxicity of sodium valproate and its mechanisms in mice: dose-concentration-response relationship. Chronobiol Int. 1989; 6: 229-35. (Pubitemid 19252283)
85. Ben-Cherif W., Dridi I, Aouam K., Ben-Attia M, Reinberg A, Boughattas NA. Chronotolerance study of the antiepileptic drug valproic acid in mice. J Circadian Rhythms. 2012; 10: 3. Excellent study evaluating variation in toxicity ofvalproate based on the timing of drug administration.
86. Ohdo S, Watanabe H, Ogawa N., Yoshiyama Y, Sugiyama T. Chronotoxicity of sodium valproate in pregnant mouse and embryo. Jpn J Pharmacol. 1996; 70: 253-8. (Pubitemid 26115607)
87. Hallam KT, Olver JS, Norman TR. Effect of sodium valproate on nocturnal melatonin sensitivity to light in healthy volunteers. Neu-ropsychopharmacology 2005; 30: 1400-4. (Pubitemid 40848094)
88. Dokucu ME, Yu L, Taghert PH. Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila. Neuro-psychopharmacology 2005; 30: 2216-24. (Pubitemid 41643972)
89. Johansson AS, Brask J, Owe-Larsson B, Hetta J., Lundkvist GB. Valproic acid phase shifts the rhythmic expression of Period2:: Luciferace. J Biol Rhythms. 2011; 26: 541-51.
90. Cicolin A, Magliola U, Giordano A., Terreni A, Bucca C, Mutani R. Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers. Epilepsia. 2006; 47: 82-5.
91. Placidi F, Diomedi M, Scalise A., Marciani MG, Romigi A, Gigli GL. Effect of anticonvulsants on nocturnal sleep in epilepsy. Neurology. 2000; 54 Suppl 1: S25-32. (Pubitemid 30151836)
92. Raol YH, Meti BL. Effects of vigabatrin on sleep-wakefulness cycle in amygdala-kindled rats. Epilepsia. 2000; 41: 128-31. (Pubitemid 30097056)
93. Molina-Carballo A., Munoz-Hoyos A, Sanchez-Forte M, Uberos-Fernandez J, Moreno-Madrid F, Acuna-Castroviejo D. Melatonin increases following convulsive seizures may be related to its anticonvulsant properties at physiological concentrations. Neuropedi-atrics. 2007; 38: 122-5. (Pubitemid 350195627)
94. Kabuto H, Yokoi I, Ogawa N. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Epilepsia. 1998; 39: 237-43. (Pubitemid 28141301)
95. Niles LP, Pickering DS, Arciszewski MA. Effects of chronic melatonin administration on GABA and diazepam binding in rat brain. J Neural Transm. 1987; 70: 117-24.
96. Brigo F, Del Felice A. Melatonin as add-on treatment for epilepsy. Cochrane Database Syst Rev. 2012; 6: CD006967.
97. Sanchez-Barcelo E.J., Mediavilla MD, Reiter RJ. Clinical uses of melatonin in pediatrics. Int J Pediatr. 2011; 2011: 892624.
98. Baxendale S, O'Sullivan J, Heaney D. Bright light therapy as an add on treatment for medically intractable epilepsy. Epilepsy Behav. 2012; 24: 359-64. This is the first published study evaluating light therapy for treatment of epilepsy.
99. Le S, Shafer PO, Bartfeld E, Fisher RS. An online diary for tracking epilepsy. Epilepsy Behav. 2011; 22: 705-9. This study evaluates the timing of seizures gathered from a cohort of patients utilizing an online seizure tracking diary system.
100. Morrell MJ. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology. 2011; 77: 1295-304. Reports the results of an implemented closed loop trial for the treatment of epilepsy.
101. Poh MZ, Loddenkemper T, Reinsberger C., Swenson NC, Goyal S, Sabtala MC, et al. Convulsive seizure detection using a wrist-worn electrodermal activity and accelerometry biosensor. Epilepsia. 2012; 53: e93-7. This study evalutes the use of a wristband which measures electrodermal conductance and accelerometry as a portable seizure detector.
102. Van Dycke A., Raedt R, Dauwe I., Sante T, Wyckhuys T, Meurs A., et al. Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures. Epilepsia. 2010; 51: 1721-8.
103. Barcia JA, Gallego JM. Intraventricular and intracerebral delivery of anti-epileptic drugs in the kindling model. Neurotherapeutics. 2009; 6: 337-43.
104. Bazil CW, Walczak TS. Effects of sleep and sleep stage on epileptic and nonepileptic seizures. Epilepsia. 1997; 38: 56-62. (Pubitemid 27057481)
105. Quigg M, Straume M, Menaker M., Bertram 3rd EH. Temporal distribution of partial seizures: comparison of an animal model with human partial epilepsy. Ann Neurol. 1998; 43: 748-55. (Pubitemid 28280218)
106. Quigg M, Straume M. Dual epileptic foci in a single patient express distinct temporal patterns dependent on limbic vs non-limbic brain location. Ann Neurol. 2000; 48: 117-20. (Pubitemid 30432441)
107. Hofstra WA, Spetgens WP, Leijten F.S., van Rijen PC, Gosselaar P, van der Palen J, et al. Diurnal rhythms in seizures detected by intracranial electrocorticographic monitoring: an observational study. Epilepsy Behav. 2009; 14: 617-21.
108. Kaleyias J, Loddenkemper T, Vendrame M., Das R, Syed TU, Alexopoulos A.V., et al. Sleep-wake patterns of seizures in children with lesional epilepsy. Pediatr Neurol. 2011; 45: 109-13.
109. Sanchez Fernandez I., Ramgopal S, Powell C., Gregas M, Zarowski M, Shah A., et al. Clinical evolution of seizures: distribution across time of day and sleep/wakefulness cycle. J Neurol. 2012; 260: 549-57.
110. Yildiz FG, Tezer FI, Saygi S. Temporal relationship between awakening and seizure onset in nocturnal partial seizures. J Neu-rol Sci. 2012; 315: 33-8.
111. Petker MA, Morton DJ. Comparison of the effectiveness of 2 oral phenytoin products and chronopharmacokinetics of phenytoin. J Clin Pharm Ther. 1993; 18: 213-7. (Pubitemid 23187049)
112. Degen PH, Flesch G, Cardot J.M., Czendlik C., Dieterle W. The influence of food on the disposition of the antiepileptic oxcarba-zepine and its major metabolites in healthy volunteers. Biopharm Drug Dispos. 1994; 15: 519-26. (Pubitemid 24255665)